Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q2 2020 · 10-Q
Revenue$25.54M$25.54M+2.7% vs Q2 2019 Net income—
EPS Diluted$0.73$0.73+192.0% vs Q2 2019 Gross Profit$15,586,000+6.9% Operating Income$4,694,000+312.5% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,425,000+75.7% Free Cash Flowderived$6,108,000— Margins · derivedGross margin61.0%+2.4 pt vs Q2 2019
Operating margin18.4%+13.8 pt vs Q2 2019
ended Sep 30, 2019 · filed Nov 6, 2019 · 37 d after period end